Literature DB >> 15035792

Pharmacology of drugs used to treat osteoarthritis in veterinary practice.

Peter Lees1.   

Abstract

As in humans, pain in animals may be associated with a wide range of conditions and circumstances, ranging from acute trauma to joint diseases. Joint diseases are common in companion animal medicine (horse, dog, cat) and at least 80% of cases are classified as osteoarthritis (OA). Several drug classes are available for OA therapy, including corticosteroids, non-steroidal antiinflammatory drugs (NSAIDs), agents with potential disease modifying properties and nutraceuticals. For long-term maintenance OA treatment, particularly in the horse and dog, NSAIDs are routinely and extensively used. This review outlines the pharmacokinetics (PK) and pharmacodynamics (PD) of NSAIDs in companion and farm animal species. NSAID PK and PD have been studied in models of acute inflammation, which enable use of PK-PD modeling to facilitate (a) studies of mechanism of action at the molecular level and (b) prediction of dosages for clinical use. The PK-PD approach is a powerful but underutilized tool which also facilitates inter-species comparisons.

Entities:  

Year:  2003        PMID: 15035792     DOI: 10.1163/156856003322699564

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  40 in total

1.  Pharmacodynamics and enantioselective pharmacokinetics of racemic carprofen in the horse.

Authors:  P Lees; M F Landoni
Journal:  J Vet Pharmacol Ther       Date:  2002-12       Impact factor: 1.786

2.  Effects of carprofen (R and S enantiomers and racemate) on the production of IL-1, IL-6 and TNF-alpha by equine chondrocytes and synoviocytes.

Authors:  S Armstrong; P Lees
Journal:  J Vet Pharmacol Ther       Date:  2002-04       Impact factor: 1.786

3.  Pharmacodynamics and pharmacokinetics of ketoprofen enantiomers in sheep.

Authors:  A K Arifah; M F Landoni; S P Frean; P Lees
Journal:  Am J Vet Res       Date:  2001-01       Impact factor: 1.156

4.  Effect of carprofen on sulfated glycosaminoglycan metabolism, protein synthesis, and prostaglandin release by cultured osteoarthritic canine chondrocytes.

Authors:  H P Benton; P B Vasseur; G A Broderick-Villa; M Koolpe
Journal:  Am J Vet Res       Date:  1997-03       Impact factor: 1.156

5.  In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats.

Authors:  C Brideau; C Van Staden; C C Chan
Journal:  Am J Vet Res       Date:  2001-11       Impact factor: 1.156

6.  Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration.

Authors:  P Lees; T Ayliffe; T E Maitho; J B Taylor
Journal:  Res Vet Sci       Date:  1988-01       Impact factor: 2.534

7.  Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in calves.

Authors:  M F Landoni; P Lees
Journal:  Chirality       Date:  1995       Impact factor: 2.437

8.  Determination of pharmacokinetics and pharmacodynamics of flunixin in calves by use of pharmacokinetic/pharmacodynamic modeling.

Authors:  M F Landoni; F M Cunningham; P Lees
Journal:  Am J Vet Res       Date:  1995-06       Impact factor: 1.156

9.  Enantioselective glucuronidation and subsequent biliary excretion of carprofen in horses.

Authors:  A Soraci; E Benoit; P Jaussaud; P Lees; P Delatour
Journal:  Am J Vet Res       Date:  1995-03       Impact factor: 1.156

10.  Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants.

Authors:  S Armstrong; P Lees
Journal:  Am J Vet Res       Date:  1999-01       Impact factor: 1.156

View more
  6 in total

1.  Pharmacokinetic/pharmacodynamic modelling of NSAIDs in a model of reversible inflammation in the cat.

Authors:  Jerome M Giraudel; Armelle Diquelou; Valerie Laroute; Peter Lees; Pierre-Louis Toutain
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

2.  Pharmacokinetics of 3 formulations of meloxicam in cynomolgus macaques (Macaca fascicularis).

Authors:  Cassondra Bauer; Patrice Frost; Stephen Kirschner
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-09       Impact factor: 1.232

3.  Pharmacokinetics and bioequivalence of 2 meloxicam oral dosage formulations in healthy adult horses.

Authors:  Melanie Vivancos; Jessica Barker; Sarah Engbers; Carrie Fischer; Jami Frederick; Heather Friedt; Joanna M Rybicka; Tereza Stastny; Heidi Banse; Alastair E Cribb
Journal:  Can Vet J       Date:  2015-07       Impact factor: 1.008

Review 4.  Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health.

Authors:  Ali Mobasheri; Yves Henrotin; Hans-Konrad Biesalski; Mehdi Shakibaei
Journal:  Int J Mol Sci       Date:  2012-03-30       Impact factor: 6.208

5.  Comparison of clinical and radiographic signs of hip osteoarthritis in contralateral hip joints of fifty working dogs.

Authors:  J C Alves; Ana Santos; Patrícia Jorge; Catarina Lavrador; L Miguel Carreira
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.752

6.  Andrographolide Exerts Chondroprotective Activity in Equine Cartilage Explant and Suppresses Interleukin-1 β -Induced MMP-2 Expression in Equine Chondrocyte Culture.

Authors:  Siriwan Tangyuenyong; Nawarat Viriyakhasem; Siriporn Peansukmanee; Prachya Kongtawelert; Siriwan Ongchai
Journal:  Int Sch Res Notices       Date:  2014-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.